Jie Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jie Chen has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Zhijun Bao
Department of Geriatrics Huadong Hospital Affiliated to Fudan University Shanghai China
10 shared publications Jiaofeng Wang
Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai, China
5 shared publications- Xiaona Hu
Department of Gastroenterology, Huadong Hospital Affiliated With Fudan University, Shanghai, China
5 shared publications Fei Xiao
Huadong Hospital Affiliated to Fudan University, Shanghai, China
4 shared publicationsJurong Zhang
Pengpu Town No.2 Community Health Service Center, Shanghai, China
4 shared publicationsWuke Yuan
Huadong Hospital Affiliated to Fudan University, Shanghai, China
4 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in Nutrition Journal
- Vol. 25 (1) , 116
Correction to: Effects of combined nutritional supplementation and exercise on proxy measures of muscle mass, strength, and function in older adults with sarcopenia: a 12-week multicentre RCT
- 28 October 2026
- Published by Springer Nature in Nutrition Journal
- Vol. 25 (1) , 116
Open AccessCorrection to: Effects of combined nutritional supplementation and exercise on proxy measures of muscle mass, strength, and function in older adults with sarcopenia: a 12-week multicentre RCT
- Open Access
- 4 August 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 1258
Sarcopenia and its associated factors among community-dwelling older adults
- 4 August 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 1258
Open AccessSarcopenia and its associated factors among community-dwelling older adults
- Open Access
- 20 January 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (3) , 106065
Development and Validation of a Skeletal Muscle Prediction Equation From Anthropometric and Demographic Data
- 20 January 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (3) , 106065
Open AccessDevelopment and Validation of a Skeletal Muscle Prediction Equation From Anthropometric and Demographic Data
- Open Access
- 5 December 2025
- Published by Springer Nature in Nutrition Journal
- Vol. 24 (1) , 180
Effects of combined nutritional supplementation and exercise on proxy measures of muscle mass, strength, and function in older adults with sarcopenia: a 12-week multicentre RCT
Although nutritional supplementation and exercise have shown independent efficacy in managing sarcopenia, data supporting their combined implementation in
- 5 December 2025
- Published by Springer Nature in Nutrition Journal
- Vol. 24 (1) , 180
Open AccessEffects of combined nutritional supplementation and exercise on proxy measures of muscle mass, strength, and function in older adults with sarcopenia: a 12-week multicentre RCT
Although nutritional supplementation and exercise have shown independent efficacy in managing sarcopenia, data supporting their combined implementation in
- Open Access
- 12 November 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-14
Serum complement C3 as a diagnostic biomarker for metabolic dysfunction -associated steatotic liver disease in middle-aged and elderly adults: a cross-sectional study
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally, with significant liver fibrosis (SLF) determining clinical outcomes. Although complement activation is involved in MASLD pathogenesis, the clinical significance of circulating complement proteins (C1q, C3, C4, total activity) in aging populations remains unclear. This cross-sectional study aimed to evaluate the association between serum complement levels and MASLD/SLF in middle-aged and elderly adults. We recruited 266 consecutive MASLD patients (age ≥ 45) and 150 age- and sex-matched healthy controls from Huadong Hospital. Multivariate logistic regression identified independent predictors of MASLD and SLF. Nonlinear relationships were assessed using restricted cubic splines. Spearman’s correlation and mediation analyses explored clinical associations, while ROC curves evaluated diagnostic performance against established non-invasive indices. MASLD patients showed significantly higher levels of C1q, C3, C4, and total complement activity than controls (P < 0.05). After multivariate adjustment, C3 was independently associated with MASLD (OR = 1.04 per mg/dL, 95% CI: 1.02–1.06; P < 0.001). A nonlinear, inverted U-shaped relationship was observed between C3 and MASLD risk (P = 0.015), with peak risk at 143 mg/dL (OR = 2.53). C3 demonstrated high diagnostic accuracy for MASLD (AUC = 0.80, 95% CI: 0.75–0.85), comparable to validated models. Although lower C3 and C4 were associated with SLF in univariate analysis, this was not sustained after adjustment. No significant association was found between complement levels and SLF. Serum C3 is a promising diagnostic biomarker for MASLD in middle-aged and elderly adults, showing a distinct nonlinear relationship and strong discriminative ability. However, complement levels were not independently associated with liver fibrosis in this population. These findings suggest a potential role for C3 in MASLD diagnosis, but the cross-sectional design precludes causal inference, and further longitudinal studies are needed to confirm its clinical utility and elucidate underlying mechanisms.
- 12 November 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-14
Open AccessSerum complement C3 as a diagnostic biomarker for metabolic dysfunction -associated steatotic liver disease in middle-aged and elderly adults: a cross-sectional study
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally, with significant liver fibrosis (SLF) determining clinical outcomes. Although complement activation is involved in MASLD pathogenesis, the clinical significance of circulating complement proteins (C1q, C3, C4, total activity) in aging populations remains unclear. This cross-sectional study aimed to evaluate the association between serum complement levels and MASLD/SLF in middle-aged and elderly adults. We recruited 266 consecutive MASLD patients (age ≥ 45) and 150 age- and sex-matched healthy controls from Huadong Hospital. Multivariate logistic regression identified independent predictors of MASLD and SLF. Nonlinear relationships were assessed using restricted cubic splines. Spearman’s correlation and mediation analyses explored clinical associations, while ROC curves evaluated diagnostic performance against established non-invasive indices. MASLD patients showed significantly higher levels of C1q, C3, C4, and total complement activity than controls (P < 0.05). After multivariate adjustment, C3 was independently associated with MASLD (OR = 1.04 per mg/dL, 95% CI: 1.02–1.06; P < 0.001). A nonlinear, inverted U-shaped relationship was observed between C3 and MASLD risk (P = 0.015), with peak risk at 143 mg/dL (OR = 2.53). C3 demonstrated high diagnostic accuracy for MASLD (AUC = 0.80, 95% CI: 0.75–0.85), comparable to validated models. Although lower C3 and C4 were associated with SLF in univariate analysis, this was not sustained after adjustment. No significant association was found between complement levels and SLF. Serum C3 is a promising diagnostic biomarker for MASLD in middle-aged and elderly adults, showing a distinct nonlinear relationship and strong discriminative ability. However, complement levels were not independently associated with liver fibrosis in this population. These findings suggest a potential role for C3 in MASLD diagnosis, but the cross-sectional design precludes causal inference, and further longitudinal studies are needed to confirm its clinical utility and elucidate underlying mechanisms.
- Open Access
- 25 April 2025
- Published by Springer Nature in Population Health Metrics
- Vol. 23 (1) , 1-14
NPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007–2020
Neutrophil-associated inflammatory markers (NPR, NHR, SII, and SIRI) have been implicated in various metabolic diseases. However, studies on these markers with metabolic dysfunction-associated steatotic liver disease (MASLD) and advanced liver fibrosis (ALF), as well as their impact on all-cause mortality, remain limited. In this historical cohort study, data from 8051 adults aged 20 years and older were analysed. Weighted logistic regression was used to investigate the associations of neutrophil-associated inflammatory markers with MASLD and ALF. Nonlinear associations were described via restricted cubic spline regression. The diagnostic utility was assessed via receiver operating characteristic (ROC) curves. Furthermore, weighted Kaplan‒Meier survival curves and Cox proportional hazards models were employed to assess all-cause mortality risk. Sensitivity analyses were employed to guarantee the robustness of the findings. Following adjustment for confounding factors, there was a significant positive association between the ln-transformed NPR, NHR, SII, and SIRI and the risk of MASLD (P < 0.001). Conversely, an inverse association was noted between the ln-transformed SII, SIRI and ALF (P < 0.05). Nonlinear relationships were identified between ln-transformed NPR, NHR, and SIRI and the risk of MASLD (P < 0.001), as well as between ln-transformed NPR, SII, and SIRI and the risk of ALF (P < 0.001). Furthermore, the ln-transformed NHR (cut-off value: − 2.571) exhibited the highest diagnostic accuracy for MASLD (AUC 0.71, 95% CI = 0.70, 0.72), whereas the NPR (cut-off value: − 3.857) demonstrated the highest diagnostic value for ALF (AUC 0.73, 95% CI = 0.70, 0.75). The results of the present study revealed an independent association between the ln-transformed NPR and an elevated risk of all-cause mortality in subjects diagnosed with MASLD. Subgroup analyses highlighted the underrepresentation of neutrophil-associated inflammatory markers in lean individuals with MASLD and ALF (BMI < 25 kg/m2). Neutrophil-associated inflammatory markers are independently associated with MASLD and ALF. Specifically, the ln-transformed NHR and SII show promise as diagnostic markers for MASLD and ALF, respectively. Moreover, elevated ln-transformed NPR is independently associated with an increased risk of all-cause mortality in individuals with MASLD, highlighting the potential clinical relevance of these inflammatory markers in the context of steatotic liver disease.
- 25 April 2025
- Published by Springer Nature in Population Health Metrics
- Vol. 23 (1) , 1-14
Open AccessNPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007–2020
Neutrophil-associated inflammatory markers (NPR, NHR, SII, and SIRI) have been implicated in various metabolic diseases. However, studies on these markers with metabolic dysfunction-associated steatotic liver disease (MASLD) and advanced liver fibrosis (ALF), as well as their impact on all-cause mortality, remain limited. In this historical cohort study, data from 8051 adults aged 20 years and older were analysed. Weighted logistic regression was used to investigate the associations of neutrophil-associated inflammatory markers with MASLD and ALF. Nonlinear associations were described via restricted cubic spline regression. The diagnostic utility was assessed via receiver operating characteristic (ROC) curves. Furthermore, weighted Kaplan‒Meier survival curves and Cox proportional hazards models were employed to assess all-cause mortality risk. Sensitivity analyses were employed to guarantee the robustness of the findings. Following adjustment for confounding factors, there was a significant positive association between the ln-transformed NPR, NHR, SII, and SIRI and the risk of MASLD (P < 0.001). Conversely, an inverse association was noted between the ln-transformed SII, SIRI and ALF (P < 0.05). Nonlinear relationships were identified between ln-transformed NPR, NHR, and SIRI and the risk of MASLD (P < 0.001), as well as between ln-transformed NPR, SII, and SIRI and the risk of ALF (P < 0.001). Furthermore, the ln-transformed NHR (cut-off value: − 2.571) exhibited the highest diagnostic accuracy for MASLD (AUC 0.71, 95% CI = 0.70, 0.72), whereas the NPR (cut-off value: − 3.857) demonstrated the highest diagnostic value for ALF (AUC 0.73, 95% CI = 0.70, 0.75). The results of the present study revealed an independent association between the ln-transformed NPR and an elevated risk of all-cause mortality in subjects diagnosed with MASLD. Subgroup analyses highlighted the underrepresentation of neutrophil-associated inflammatory markers in lean individuals with MASLD and ALF (BMI < 25 kg/m2). Neutrophil-associated inflammatory markers are independently associated with MASLD and ALF. Specifically, the ln-transformed NHR and SII show promise as diagnostic markers for MASLD and ALF, respectively. Moreover, elevated ln-transformed NPR is independently associated with an increased risk of all-cause mortality in individuals with MASLD, highlighting the potential clinical relevance of these inflammatory markers in the context of steatotic liver disease.
- Open Access
- 25 September 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1189192
High blood galectin-3 level associated with risk of frailty in aging
Background: Frailty is one of the most problematic expressions of population aging, but its underlying mechanism has not been fully elucidated. Circulating galectin-3 (Gal-3) is involved in the pathogenesis of many age-related diseases. This study aims to explore the influence of circulating Gal-3 on the regulation of frailty and aging and to identify the potential mechanism further.Methods: In this cross-sectional analysis, the Fried frailty phenotype (FP) was assessed among 149 community elderly residents in Shanghai. Peripheral blood mononuclear cells (PBMCs) were isolated by the Ficoll-Paque density gradient method, and differentially expressed genes (DEGs) encoding transcription factors in frailty were detected by Illumina and bioinformatics analyzed with R software. Gene Ontology (GO) enrichment analyses and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to explore the functional roles of these DEGs and the target genes related to frailty phenotypes. The serum Gal-3 concentration was tested by enzyme-linked immunosorbent assay (ELISA). Mouse frailty phenotype was used to construct an in vivo model of frailty, after which the serum levels of circulating Gal-3 and its gene expression levels in mouse tissues were determined.Results: Participants’ mean age was 72.04 ± 7.05 years. In total, 21.48% were frail and 36.91% were pre-frail. The mean serum Gal-3 concentration was 46.34 ± 17.99 ng/mL in frail participants, 32.30 ± 8.14 ng/mL in pre-frail participants, and 26.00 ± 5.87 ng/mL in non-frail individuals (p < 0.001). Significant positive correlations between serum Gal-3 level and FP score, SARC-F score, C-reactive protein (CRP), interleukin-6, etc., were observed. In addition, the KEGG pathway and GO enrichment analyses showed that 265 DEGs in PBMCs of frail participants were mainly related to inflammatory response, translation, RNA binding, protein binding, ribosome, and primary immunodeficiency. LGALS3 was identified as the overlapping gene between frailty-related DEGs and aging-related DEGs. The elevated serum Gal-3 concentration in the in vivo model of frailty was consistent with the results in participants.Conclusion: In both community-dwelling older adults and aged mice, serum Gal-3 concentration was positively correlated with frailty. This circulating mediator may be a promising indicator of frailty.Clinical trial registration: Chinese Clinical Trial Registry identifier, ChiCTR2000036399.
- 25 September 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1189192
Open AccessHigh blood galectin-3 level associated with risk of frailty in aging
Background: Frailty is one of the most problematic expressions of population aging, but its underlying mechanism has not been fully elucidated. Circulating galectin-3 (Gal-3) is involved in the pathogenesis of many age-related diseases. This study aims to explore the influence of circulating Gal-3 on the regulation of frailty and aging and to identify the potential mechanism further.Methods: In this cross-sectional analysis, the Fried frailty phenotype (FP) was assessed among 149 community elderly residents in Shanghai. Peripheral blood mononuclear cells (PBMCs) were isolated by the Ficoll-Paque density gradient method, and differentially expressed genes (DEGs) encoding transcription factors in frailty were detected by Illumina and bioinformatics analyzed with R software. Gene Ontology (GO) enrichment analyses and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to explore the functional roles of these DEGs and the target genes related to frailty phenotypes. The serum Gal-3 concentration was tested by enzyme-linked immunosorbent assay (ELISA). Mouse frailty phenotype was used to construct an in vivo model of frailty, after which the serum levels of circulating Gal-3 and its gene expression levels in mouse tissues were determined.Results: Participants’ mean age was 72.04 ± 7.05 years. In total, 21.48% were frail and 36.91% were pre-frail. The mean serum Gal-3 concentration was 46.34 ± 17.99 ng/mL in frail participants, 32.30 ± 8.14 ng/mL in pre-frail participants, and 26.00 ± 5.87 ng/mL in non-frail individuals (p < 0.001). Significant positive correlations between serum Gal-3 level and FP score, SARC-F score, C-reactive protein (CRP), interleukin-6, etc., were observed. In addition, the KEGG pathway and GO enrichment analyses showed that 265 DEGs in PBMCs of frail participants were mainly related to inflammatory response, translation, RNA binding, protein binding, ribosome, and primary immunodeficiency. LGALS3 was identified as the overlapping gene between frailty-related DEGs and aging-related DEGs. The elevated serum Gal-3 concentration in the in vivo model of frailty was consistent with the results in participants.Conclusion: In both community-dwelling older adults and aged mice, serum Gal-3 concentration was positively correlated with frailty. This circulating mediator may be a promising indicator of frailty.Clinical trial registration: Chinese Clinical Trial Registry identifier, ChiCTR2000036399.
- Open Access
- 30 June 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 931928
Identifying Autophagy-Related lncRNAs and Potential ceRNA Networks in NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease with complex pathogenesis, which brings economic burden to the society, and there is still no effective therapy. Impaired autophagy has been implicated in the development of NAFLD. Long noncoding RNAs (lncRNAs) are also reported to play a role in the pathogenesis of NAFLD. However, the role of autophagy-related lncRNAs in NAFLD disease has not been elucidated. Here, we mined GSE135251, GSE160016, GSE130970 and GSE185062 datasets from the Gene Expression Omnibus database (GEO) and obtained the human autophagy-related gene list from the Human Autophagy Database (HADb) for in-depth bioinformatic analysis. Following differential expression analysis and intersection of the datasets, Pearson correlation analysis was performed on DElncRNAs and autophagy-related DEmRNAs to obtain autophagy-related lncRNAs, and then Starbase3.0 and TargetScan7.2 were used to construct competing endogenous RNAs (ceRNA) regulatory networks. We constructed four lncRNA-dominated ceRNA regulatory networks (PSMG3-AS1, MIRLET7BHG, RP11-136K7.2, LINC00925), and visualized with Cytoscape. Then we performed co-expression analysis of the ceRNA networks and autophagy-related genes, and functionally annotated them with Metascape. Finally, we performed receiver operating characteristic curve (ROC) analysis on lncRNAs and mRNAs within the ceRNA networks. Conclusively, our project is the first to study autophagy-related lncRNAs in NAFLD and finally mined four autophagy-related lncRNAs (PSMG3-AS1, MIRLET7BHG, RP11-136K7.2, LINC00925). We suggested that the four autophagy-related lncRNAs may be closely associated with the occurrence and development of NAFLD through the corresponding ceRNA regulatory networks. This research brings new horizons to the study of NAFLD.
- 30 June 2022
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 931928
Open AccessIdentifying Autophagy-Related lncRNAs and Potential ceRNA Networks in NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease with complex pathogenesis, which brings economic burden to the society, and there is still no effective therapy. Impaired autophagy has been implicated in the development of NAFLD. Long noncoding RNAs (lncRNAs) are also reported to play a role in the pathogenesis of NAFLD. However, the role of autophagy-related lncRNAs in NAFLD disease has not been elucidated. Here, we mined GSE135251, GSE160016, GSE130970 and GSE185062 datasets from the Gene Expression Omnibus database (GEO) and obtained the human autophagy-related gene list from the Human Autophagy Database (HADb) for in-depth bioinformatic analysis. Following differential expression analysis and intersection of the datasets, Pearson correlation analysis was performed on DElncRNAs and autophagy-related DEmRNAs to obtain autophagy-related lncRNAs, and then Starbase3.0 and TargetScan7.2 were used to construct competing endogenous RNAs (ceRNA) regulatory networks. We constructed four lncRNA-dominated ceRNA regulatory networks (PSMG3-AS1, MIRLET7BHG, RP11-136K7.2, LINC00925), and visualized with Cytoscape. Then we performed co-expression analysis of the ceRNA networks and autophagy-related genes, and functionally annotated them with Metascape. Finally, we performed receiver operating characteristic curve (ROC) analysis on lncRNAs and mRNAs within the ceRNA networks. Conclusively, our project is the first to study autophagy-related lncRNAs in NAFLD and finally mined four autophagy-related lncRNAs (PSMG3-AS1, MIRLET7BHG, RP11-136K7.2, LINC00925). We suggested that the four autophagy-related lncRNAs may be closely associated with the occurrence and development of NAFLD through the corresponding ceRNA regulatory networks. This research brings new horizons to the study of NAFLD.
- Open Access
- 10 May 2022
- Published by Wiley in Mathematical Problems in Engineering
- Vol. 2022, 1-17
Establishment and Analysis of a Combined Diagnostic Model of Liver Cancer with Random Forest and Artificial Neural Network
The incidence of liver cancer (hepatocellular carcinoma; HCC) is rising and with poor clinical outcome expected, a more accurate judgment of tumor tissues and adjacent nontumor tissues is necessary. The aim of this study was to construct a diagnostic model based on random forest (RF) and artificial neural network (ANN). It can be used to aid in the identification of diseased tissue such as cancerous tissue, for HCC clinical diagnosis and surgical guidance. GSE36376 and GSE121248 from Gene Expression Omnibus (GEO) were used as training sets in this investigation. R package “limma” and WGCNA were used to filter the training set for statistically significant differential genes. To better understand the biological function and characteristics, R software was used to perform GO and KEGG enrichment analyses. To pick out and further understand the key genes, we performed PPI analysis and random forest tree analysis. Next, we built the ANN to predict training sets and validation set (GSE84402), and ROC curve was plotted to calculate area under curve (AUC). Then immune cell infiltration indicated difference of immune cell subsets between control and case groups. Finally, the survival analysis of key genes was also carried out based on data in TCGA database. Based on the expression of these 9 genes, we built the artificial neural network (ANN) and the accuracy of the final models was assessed with an ROC curve. The areas under the ROC curve were 0.984 (95% CI 0.972–0.993) in training sets. Its predictive capability was further assessed using the validation set. And the areas under the ROC curve were 0.929 (95% CI 0.786–1.000). In summary, this method effectively classifies hepatocellular carcinoma tissues and the corresponding noncancerous tissues and provides reasonable new ideas for the early diagnosis of liver cancer in the future.
- 10 May 2022
- Published by Wiley in Mathematical Problems in Engineering
- Vol. 2022, 1-17
Open AccessEstablishment and Analysis of a Combined Diagnostic Model of Liver Cancer with Random Forest and Artificial Neural Network
The incidence of liver cancer (hepatocellular carcinoma; HCC) is rising and with poor clinical outcome expected, a more accurate judgment of tumor tissues and adjacent nontumor tissues is necessary. The aim of this study was to construct a diagnostic model based on random forest (RF) and artificial neural network (ANN). It can be used to aid in the identification of diseased tissue such as cancerous tissue, for HCC clinical diagnosis and surgical guidance. GSE36376 and GSE121248 from Gene Expression Omnibus (GEO) were used as training sets in this investigation. R package “limma” and WGCNA were used to filter the training set for statistically significant differential genes. To better understand the biological function and characteristics, R software was used to perform GO and KEGG enrichment analyses. To pick out and further understand the key genes, we performed PPI analysis and random forest tree analysis. Next, we built the ANN to predict training sets and validation set (GSE84402), and ROC curve was plotted to calculate area under curve (AUC). Then immune cell infiltration indicated difference of immune cell subsets between control and case groups. Finally, the survival analysis of key genes was also carried out based on data in TCGA database. Based on the expression of these 9 genes, we built the artificial neural network (ANN) and the accuracy of the final models was assessed with an ROC curve. The areas under the ROC curve were 0.984 (95% CI 0.972–0.993) in training sets. Its predictive capability was further assessed using the validation set. And the areas under the ROC curve were 0.929 (95% CI 0.786–1.000). In summary, this method effectively classifies hepatocellular carcinoma tissues and the corresponding noncancerous tissues and provides reasonable new ideas for the early diagnosis of liver cancer in the future.